A securities class action has been initiated against PomDoctor Ltd., alleging the company engaged in a coordinated scheme involving false statements, social media-based market manipulation, and undisclosed insider selling through offshore entities. The litigation targets investors who acquired PomDoctor securities during the period spanning October 9, 2025 through December 11, 2025, a timeframe when the company's stock allegedly benefited from artificial trading activity that artificially inflated share valuations.
The case centers on claims that company insiders utilized offshore accounts to liquidate shareholdings while simultaneously promoting the stock through misleading social media content and coordinated trading strategies designed to artificially increase demand. Investors affected during this window are being advised to seek legal counsel to evaluate their potential eligibility for compensation recovery.
Prospective lead plaintiffs in the class action must meet a filing deadline of April 7, 2026. Legal counsel specializing in securities litigation recommend that eligible investors review their transaction records and consult with qualified attorneys to understand their rights and options within the established timeline.